Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors.

1. The potent, antimigraine drug ergotamine has affinity for both 5-HT1 and 5-HT2 binding sites and constricts arteriovenous anastomoses. Since 5-HT also constricts arteriovenous anastomoses (mainly via 5-HT1-like receptors), this study investigates the involvement of 5-HT receptors in the ergotamin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bom, A. H., Heiligers, J. P., Saxena, P. R., Verdouw, P. D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 1989
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1854530/
https://ncbi.nlm.nih.gov/pubmed/2758221
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi